Balyasny Asset Management L.P.

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1218710 Chicago, IL

Position in RCKT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$927,245

-$479,233 QoQ

Shares Held

259,007

-35.4% QoQ

Ownership

0.237%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. RCKT ranks #136 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	2,779,445	$146,532,340
2	ERAS	Erasca, Inc.	5,143,985	$83,229,677
3	TNGX	Tango Therapeutics, Inc.	3,826,659	$80,053,706
4	APLS	Apellis Pharmaceuticals, Inc.	1,917,501	$77,141,065
5	BMRN	Biomarin Pharmaceutical Inc	1,362,752	$76,981,860
6	CYTK	Cytokinetics Inc	992,545	$65,418,640
7	DAWN	Day One Biopharmaceuticals, Inc.	2,625,235	$56,285,038
8	FOLD	AMICUS THERAPEUTICS, INC.	3,827,513	$55,345,837

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$927,245	259,007	-35.4%	Shares	Sole	2026-05-15
2025-12-31	$1,406,478	400,706	-69.5%	Shares	Sole	2026-02-17
2025-09-30	$4,282,782	1,313,737	+896.7%	Shares	Sole	2025-11-14
2025-06-30	$322,924	131,806	-62.7%	Shares	Sole	2025-08-14
2025-03-31	$2,354,223	352,957	+931.9%	Shares	Sole	2025-05-15
2023-09-30	$700,860	34,205	+6210.9%	Shares	Sole	2023-11-14
2022-12-31	$10,606	542	-98.9%	Shares	Other	2023-02-14
2022-09-30	$794,328	49,770	—	Shares	Other	2022-11-15
No filing history on record for this holder in this stock.